Recent Events

The Directors Roundtable Invites You to Attend a Program
For Boards of Directors and Their Advisors

WORLD RECOGNITION OF DISTINGUISHED GENERAL COUNSEL:
CORNELIS “KEES” VAN OPHEM
GENERAL COUNSEL OF FRESENIUS MEDICAL CARE

Friday, September 30, 2016, 8:30 – 10:45 A.M. (8:00 Registration)
Fish & Richardson Conference Center, One Marina Park Drive, Boston

There is no fee to attend and continental breakfast will be served.

Agenda

General Counsel are more important than ever in history.  Boards of Directors look increasingly to them to enhance financial and business strategy, compliance, and integrity of corporate operations. In recognition of our distinguished Guest of Honor’s personal accomplishments in his career and his leadership in the profession, we are honoring Cornelis “Kees” van Ophem, General Counsel of Fresenius Medical Care with the leading global honor for General Counsel.  Fresenius Medical Care is a leading global provider of vertically integrated solutions, including products and services for people with chronic kidney failure and other chronic diseases.  His address will focus on key issues facing the General Counsel of a global medical products and services corporation with a dual stock exchange listing at NYSE and the DAX in Frankfurt.  The panelists’ additional topics include business & regulatory globalization; intellectual property; trade & commerce; and mergers & acquisitions. The transcript of this event will be made available worldwide in electronic copy.

Distinguished Speakers

GUEST OF HONOR
Cornelis “Kees” van Ophem

Executive Vice President & Global General Counsel
Fresenius Medical Care

DISTINGUISHED PANELISTS
Dr. Ulf Wauschkuhn

Partner, Baker & McKenzie

Joseph “Joe” Andrew
Global Chairman, Dentons

Michael Florey
Principal, Fish & Richardson

Scott Sonnenblick
Partner, Linklaters LLP

Graham Robinson
Partner, Skadden, Arps, Slate, Meagher & Flom LLP

Jack Friedman (Moderator)
Chairman, Directors Roundtable

Rick Williams, Partner, Newport Board Group, LLC
will make introductory remarks.